An Experimental Study on Production of Egg Yolk Antibody(IgY) against Bee Venom
Hwang, Tae-Jun; Lee, Seung-Bae; Gwon, Gi-Rok
This study was carried out for production of neutral antibody to bee venom
$})
. Hen layings were injected repeatedly with bee venom and phospholipase

with Freund's adjuvant. Specific antibody in egg yolk from immunized hen laying was separated, and purified, also immunological characteristics of anti phospholipase

was invested. The results were summarized as follows: 1. Phospholipase

was showed single band at molecular weight 17,000 in SDS-PAGE and bee venom was showed two band at molecular weight 17,000 and under molecular weight 6,500 in SDS-PAGE. 2. During 70 days after hen immunized with bee venom and phospholipase

, antibodies(anti-bee venom IgY) to bee venom were showed poor ELISA value in egg yolk, but antibodies
$})
to phospholipase

in egg yolk were increased ELISA value from 8 days or 15 days and found maximum ELISA value at 42 days. Also after booster at 49 days, ELISA value of anti Phospholipase

in egg yolk was supported at optical density(O.D) 1.0 level, continuously. 3. Titer of phospholipase

was showed 1: 32,000. 4. In double immunodiffusion test to phospholipase

after double dilution of anti-phospholipase

, only precipitation line was made in 1:1 dilution well of anti-Phospholipase

. But In immunodiffusion test to anti-phospholipase

after double dilution of phospholipase

, Precipitation line to 250ul/ml well of phospholipase

was showed. In double immunodiffusion test to bee venom(1mg/ml) after double dilution anti-phospholipase

, all well without 1:32 dilution well were showed strong precipitation line. 5. In dot bloting test to anti-phospholipase

after diluting bee venom(0.5mg/ml), dot bloting color was showed clearly to
$})
in bee venom.
Egg Yolk Antibody(IgY) against Bee Venom; IgY; Anti body of Bee venom; Korean Bee Venom Therapy
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (
http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © 2014 Journal of Pharmacopuncture. All rights reserved.